Atjaunināt sīkdatņu piekrišanu

Elsevier's 2026 Intravenous Medications 42nd edition [Spiral bound]

(President, Drug Information Consultants, Chesapeake, Virginia, USA)
  • Formāts: Spiral bound, 1360 pages, height x width: 229x152 mm, weight: 1750 g
  • Izdošanas datums: 05-Jun-2025
  • Izdevniecība: Churchill Livingstone
  • ISBN-10: 0443269599
  • ISBN-13: 9780443269592
Citas grāmatas par šo tēmu:
  • Spiral bound
  • Cena: 59,91 €
  • Grāmatu piegādes laiks ir 3-4 nedēļas, ja grāmata ir uz vietas izdevniecības noliktavā. Ja izdevējam nepieciešams publicēt jaunu tirāžu, grāmatas piegāde var aizkavēties.
  • Daudzums:
  • Ielikt grozā
  • Piegādes laiks - 4-6 nedēļas
  • Pievienot vēlmju sarakstam
  • Formāts: Spiral bound, 1360 pages, height x width: 229x152 mm, weight: 1750 g
  • Izdošanas datums: 05-Jun-2025
  • Izdevniecība: Churchill Livingstone
  • ISBN-10: 0443269599
  • ISBN-13: 9780443269592
Citas grāmatas par šo tēmu:
**Selected for 2025 Doodys Core Titles® with "Essential Purchase" designation in Medical/Surgical**

Find the essential information you need to safely administer more than 400 intravenous drugs! For nearly 50 years, Elseviers Intravenous Medications: A Handbook for Nurses and Health Professionals has been a trusted resource for complete, accurate drug information in a concise, quick-access format. New to the 2026 edition are 8 monographs of the most recent IV drugs to be approved by the FDA, in addition to updated drug uses, interactions, precautions, alerts, and patient teaching instructions for all current IV drugs. Known as the #1 IV drug handbook on the market, this annual publication is ideal for use in critical care areas, at the nursing station, in the office, and in public health and home care settings.

Detailed monographs on more than 400 IV drugs provide an impressive breadth of coverage that goes well beyond any comparable drug reference Individual monographs include the drug name, phonetic pronunciation, usual dose, dilution, compatibility, rate of administration, actions, indications and uses, contraindications, precautions, interactions, side effects, antidote, and more Additional drug monographs are provided on the Evolve website Highlighted Black Box Warnings make it easy to locate information on medications with serious safety risks Blue-screened text calls attention to special circumstances not covered by Black Box Warnings Dosage and dilution charts within monographs provide quick summaries of essential clinical information Life-stage dosage variances are highlighted for geriatric, pediatric, infant, and neonatal patients Convenient, A-to-Z format organizes all drug monographs by generic name, allowing you to find any drug in seconds Spiral binding allows the book to lie flat, leaving your hands free to perform other tasks. NEW! Drug monographs for 8 newly approved drugs by the FDA include the most current information NEW! Updates on drug uses, interactions, precautions, alerts, and more are included throughout the guide to reflect changes to existing medications NEW! Best practices guidelines for the preparation and administration of injectable drugs are provided from the National Coalition for IV Push Safety
General Dilution Charts (inside front cover and facing page)
How to Use This Book Evolve Website Information Format and Content of Intravenous Medications Key to Abbreviations Important IV Therapy Facts Resources IV Drugs [ alphabetical drug monographs]

Appendix
A. Recommendations for the Safe Use and Handling of Cytotoxic Drugs
B. FDA Pregnancy Categories
C. U.S. Department of Health and Human Services, National Institutes of Health, and National Cancer Institute Common Terminology Criteria for Adverse Events
D. Information for Patients Receiving Immunosuppressive Agents
E. Recently Approved Drugs
Shelly Collins, PharmD, has decades of clinical experience in which she has been responsible for overseeing system-wide pharmaceutical safety.